title: Aprotinin, but not tranexamic acid, is associated with increased pulmonary microvascular fibrin deposition after cardiac surgery.
authors.forename: Barry
authors.initials: B
authors.lastname: Dixon
authors.forename: Ian
authors.initials: I
authors.lastname: Nixon
authors.forename: James
authors.initials: J
authors.lastname: Kenny
authors.forename: Andrew E
authors.initials: AE
authors.lastname: Newcomb
authors.forename: Alexander
authors.initials: A
authors.lastname: Rosalion
authors.forename: Kenneth
authors.initials: K
authors.lastname: Opeskin
authors.forename: Georgia
authors.initials: G
authors.lastname: Stamaratis
authors.forename: Brendan S
authors.initials: BS
authors.lastname: Silbert
authors.forename: S
authors.initials: S
authors.lastname: Said
authors.forename: John D
authors.initials: JD
authors.lastname: Santamaria
authors.forename: Duncan J
authors.initials: DJ
authors.lastname: Campbell
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D007611:Aprotinin / Q000009:adverse effects*; D016022:Case-Control Studies; D005337:Fibrin / Q000378:metabolism*; D006801:Humans; D008168:Lung / Q000098:blood supply* / Q000187:drug effects / Q000473:pathology; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D008875:Middle Aged; D013903:Thoracic Surgery; D014148:Tranexamic Acid / Q000009:adverse effects*
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D005337:Fibrin; D007611:Aprotinin